Eli Lilly And Co (NYSE:LLY) has agreed to acquire DICE Therapeutics Inc (NASDAQ:DICE), a biopharmaceutical company that leverages its proprietary DELSCAPE technology platform to develop oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results